Use of non-absorbable synthetic sulfated polysaccharides to decr

Details Use of non-absorbable synthetic sulfated polysaccharides to decr Use of non-absorbable synthetic sulfated polysaccharides to decr

1994-08-01

1997-04-01

Sayala, Chhaya D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 55, 514 57, 514 59, 424439, 426658, 435196, A61K 3172

Patent

active

056165706

ABSTRACT:
This invention encompasses a method and compositions which inhibit pancreatic cholesterol esterase and triglyceride lipase and hence, lower cholesterol and triglycerides in the blood stream.

REFERENCES:
patent: 3511910 (1970-05-01), Halleck
patent: 3627872 (1971-12-01), Parkinson
patent: 4223023 (1980-09-01), Furda
patent: 4436731 (1984-03-01), Maltz
patent: 4623539 (1986-11-01), Tunc
patent: 5017565 (1991-05-01), Lange et al.
patent: 5063210 (1991-11-01), Lange, III et al.
patent: 5484777 (1996-01-01), Lange, III et al.
Bosner et al, Proc. Natl. Acad. Sci U.S.A, "Receptor-like Function of Haparin in the Binding and Uptake of Neutral Lipids", vol. 85, pp. 7438-7442, Oct. 1988.
Goto et al, J. Clin. Biochem. Nutr., "Effect of Dextran Sulfate (MDS) on Prevention of Ischemic Heart Disease Blind Primary Prevention Trail", 2: 55-70, 1987.

Affiliated with

Also associated with

Rating

Use of non-absorbable synthetic sulfated polysaccharides to decr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of non-absorbable synthetic sulfated polysaccharides to decr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of non-absorbable synthetic sulfated polysaccharides to decr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-538971